PERSISTENT ENHANCEMENT OF CELL-MEDIATED AND ANTIBODY IMMUNE-RESPONSES AFTER ADMINISTRATION OF MURAMYL DIPEPTIDE DERIVATIVES WITH ANTIGEN IN METABOLIZABLE OIL

被引：24

作者：

CARELLI, C ^{[1
]}

AUDIBERT, F ^{[1
]}

CHEDID, L ^{[1
]}

机构：

[1] INST PASTEUR,F-75724 PARIS 15,FRANCE

来源：

INFECTION AND IMMUNITY | 1981年 / 33卷 / 01期

关键词：

D O I：

10.1128/IAI.33.1.312-314.1981

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：312 / 314

页数：3

共 14 条

[1]

AUDIBERT F, 1977, ANN INST PASTEUR IMM, VC128, P653

[2] DISTINCTIVE ADJUVANTICITY OF SYNTHETIC ANALOGS OF MYCOBACTERIAL WATER-SOLUBLE COMPONENTS [J].

AUDIBERT, F ;

CHEDID, L ;

LEFRANCIER, P ;

CHOAY, J .

CELLULAR IMMUNOLOGY, 1976, 21 (02) :243-249

[3] ADJUVANT ACTIVITY OF MYCOBACTERIAL FRACTIONS - ADJUVANT ACTIVITY OF SYNTHETIC N-ACETYLMURAMYL-DIPEPTIDE AND RELATED COMPOUNDS [J].

AZUMA, I ;

SUGIMURA, K ;

TANIYAMA, T ;

YAMAWAKI, M ;

YAMAMURA, Y ;

KUSUMOTO, S ;

OKADA, S ;

SHIBA, T .

INFECTION AND IMMUNITY, 1976, 14 (01) :18-27

[4]

BOMFORD R, 1980, CLIN EXP IMMUNOL, V39, P426

[5] MINIMAL STRUCTURAL REQUIREMENTS FOR ADJUVANT ACTIVITY OF BACTERIAL PEPTIDOGLYCAN DERIVATIVES [J].

ELLOUZ, F ;

ADAM, A ;

CIORBARU, R ;

LEDERER, E .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1974, 59 (04) :1317-1325

[6]

HOLT LB, 1967, S SERIES IMMUNOBIOL, V6, P131

[7]

KOTANI S, 1975, BIKEN J, V18, P105

[8] SYNTHETIC IMMUNOSTIMULANTS DERIVED FROM THE BACTERIAL-CELL WALL [J].

LEDERER, E .

JOURNAL OF MEDICINAL CHEMISTRY, 1980, 23 (08) :819-825

[9] IMMUNOSTIMULANT ACTIVITIES OF A LIPOPHILIC MURAMYL DIPEPTIDE DERIVATIVE AND OF DESMURAMYL PEPTIDOLIPID ANALOGS [J].

PARANT, MA ;

AUDIBERT, FM ;

CHEDID, LA ;

LEVEL, MR ;

LEFRANCIER, PL ;

CHOAY, JP ;

LEDERER, E .

INFECTION AND IMMUNITY, 1980, 27 (03) :826-831

[10] PEPTIDES AS REQUIREMENT FOR IMMUNOTHERAPY OF THE GUINEA-PIG LINE-10 TUMOR WITH ENDOTOXINS [J].

RIBI, E ;

PARKER, R ;

STRAIN, SM ;

MIZUNO, Y ;

NOWOTNY, A ;

VONESCHEN, KB ;

CANTRELL, JL ;

MCLAUGHLIN, CA ;

HWANG, KM ;

GOREN, MB .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 1979, 7 (01) :43-58

← 1 2 →